» Articles » PMID: 9020077

Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype

Overview
Journal Science
Specialty Science
Date 1997 Feb 14
PMID 9020077
Citations 319
Authors
Affiliations
Soon will be listed here.
Abstract

Cancers of the microsatellite mutator phenotype (MMP) show exaggerated genomic instability at simple repeat sequences. More than 50 percent (21 out of 41) of human MMP+ colon adenocarcinomas examined were found to have frameshift mutations in a tract of eight deoxyguanosines [(G)8] within BAX, a gene that promotes apoptosis. These mutations were absent in MMP- tumors and were significantly less frequent in (G)8 repeats from other genes. Frameshift mutations were present in both BAX alleles in some MMP+ colon tumor cell lines and in primary tumors. These results suggest that inactivating BAX mutations are selected for during the progression of colorectal MMP+ tumors and that the wild-type BAX gene plays a suppressor role in a p53-independent pathway for colorectal carcinogenesis.

Citing Articles

Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer.

Zhang L, Wei Y, Luo M, Ren S, Zhan X, Wang C Cell Death Dis. 2025; 16(1):170.

PMID: 40075071 PMC: 11904182. DOI: 10.1038/s41419-025-07481-8.


Senolysis by ABT-263 is associated with inherent apoptotic dependence of cancer cells derived from the non-senescent state.

Jochems F, Baltira C, MacDonald J, Daniels V, Mathur A, de Gooijer M Cell Death Differ. 2024; .

PMID: 39706991 DOI: 10.1038/s41418-024-01439-7.


Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.

Trembath H, Yeh J, Lopez N Cancer Treat Res. 2024; 192:305-418.

PMID: 39212927 DOI: 10.1007/978-3-031-61238-1_15.


Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation.

Jonchere V, Montemont H, Le Scanf E, Siret A, Letourneur Q, Tubacher E Genome Biol. 2024; 25(1):210.

PMID: 39107855 PMC: 11304650. DOI: 10.1186/s13059-024-03340-5.


Tumor biomarkers for diagnosis, prognosis and targeted therapy.

Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y Signal Transduct Target Ther. 2024; 9(1):132.

PMID: 38763973 PMC: 11102923. DOI: 10.1038/s41392-024-01823-2.